Details of the Drug
General Information of Drug (ID: DM3W6PQ)
| Drug Name |
CT-003230
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Synonyms |
CT-0011; CT-007640; CT-007650; CT-007660; CT-007670; CT-007680; CT-008650; CT-0093; CT-0107; CT-0109; Amyloid beta 1-42 inhibitors (Alzheimers/mild cognitive impairment/Downs' syndrome); Amyloid beta 1-42 inhibitors (Alzheimers/mild cognitive impairment/Downs' syndrome), Cognition
|
||||||||||||||||||
| Indication |
|
||||||||||||||||||
| Cross-matching ID | |||||||||||||||||||
Molecular Interaction Atlas of This Drug
![]() Drug Therapeutic Target (DTT) |
|
||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Molecular Interaction Atlas (MIA) | |||||||||||||||||||||
Molecular Expression Atlas of This Drug
| The Studied Disease | Cognitive impairment | |||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ICD Disease Classification | 6D71 | |||||||||||||||||
|
||||||||||||||||||
| Molecular Expression Atlas (MEA) | ||||||||||||||||||

